This inventor holds 1 USPTO granted patent. Top assignee: Futurechem Co., Ltd. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Woon-Jung Jung: Innovator in Radiopharmaceutical Manufacturing
Introduction: Woon-Jung Jung is a notable inventor based in Seoul, South Korea, with a focus on advancements in the field of radiopharmaceuticals. His innovative contributions, particularly in the development of precursor compounds, have the potential to significantly streamline manufacturing processes in this specialized area of medicine.
Latest Patents: Jung holds a significant patent titled "Precursor compound connected to solid support for manufacturing 18F radiopharmaceutical, method for manufacturing same, and application thereof." This ingenious invention relates to a solid precursor in the form of an organic salt. The solid precursor improves the manufacturing process by eliminating the need for a fluoride refining process using additional cartridges and reducing the use of excessive phase-transfer catalysts. Furthermore, the design allows for easy removal of residual substances after the reaction, making it highly suitable for automated synthesis devices.
Career Highlights: Woon-Jung Jung is associated with Futurechem Co., Ltd., a company that specializes in the development of innovative chemical compounds and processes. His work within this forward-thinking organization showcases his commitment to enhancing methodologies in the field of radiopharmaceuticals.
Collaborations: Throughout his career, Jung has collaborated with esteemed colleagues such as Dae-Yoon Chi and Byoung-Se Lee. These partnerships have been integral in advancing his research and the successful application of his inventions.
Conclusion: Woon-Jung Jung stands out as a key innovator in the realm of radiopharmaceutical manufacturing. His patented solid precursor technology not only simplifies existing processes but also enhances the efficiency of automated synthesis systems. As the field continues to evolve, contributions like those of Jung will undoubtedly play a crucial role in shaping the future of medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile